🇺🇸 FDA
Patent

US 11077068

Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions

granted A61KA61K31/355A61K31/485

Quick answer

US patent 11077068 (Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions) held by Aquestive Therapeutics, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aquestive Therapeutics, Inc.
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/355, A61K31/485, A61K47/02, A61K47/12